首页> 美国卫生研究院文献>Endoscopy International Open >Wide disparities in attitudes and practices regarding Type II sphincter of Oddi dysfunction: a survey of expert U.S. endoscopists
【2h】

Wide disparities in attitudes and practices regarding Type II sphincter of Oddi dysfunction: a survey of expert U.S. endoscopists

机译:关于Oddi功能异常的II型括约肌的态度和实践存在巨大差异:对美国内镜专家的调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Sphincter of Oddi manometry (SOM) is recommended in the evaluation of suspected Type II sphincter of Oddi dysfunction (SOD2), though its utility is uncertain. Little is known about the practice of expert endoscopists in the United States regarding SOD2. >Methods: An anonymous electronic survey was distributed to 128 expert biliary endoscopists identified from U.S. advanced endoscopy training programs. >Results: The response rate was 46.1 % (59/128). Only 55.6 % received training in SOM, and 49.2 % currently perform SOM. For biliary SOD2, 33.3 % routinely obtain SOM, 33.3 % perform empiric sphincterotomy, and 26.3 % perform single session endoscopic ultrasound/endoscopic retrograde cholangiopancreatography (EUS/ERCP). In contrast, an equal number (35.1 %) favor SOM or single session EUS/ERCP for suspected acute idiopathic recurrent pancreatitis, while 19.3 % would perform empiric sphincterotomy. Those who perform SOM believe it to be important in predicting response to treatment compared with those who do not (71.8 % vs 23.1 %, P = 0.01). Yet only 51.7 % of this group performs SOM for suspected SOD2. Most (78.6 %) believe that < 50 % of patients report improvement in symptoms after sphincterotomy. Common reasons for not obtaining SOM included unreliable results (50 %), and procedure-related risks (39.3 %). Most (59.3 %) believe SOD2 is at least in part a functional disorder; only 3.7 % felt SOD is a legitimate disorder of the sphincter of Oddi. >Conclusions: Our survey of U.S. expert endoscopists suggests that SOM is not routinely performed for SOD2 and concerns regarding its associated risks and validity persist. Most endoscopists believe SOD2 is at least in part a functional disorder that will not respond to sphincterotomy in the majority of cases.
机译:>背景:尽管不确定其实用性,但推荐在评估可疑的Oddi II型括约肌(SOD2)时推荐使用Oddi括约肌测压(SOM)。关于美国内镜专家对SOD2的实践知之甚少。 >方法:匿名电子调查已分发给从美国高级内窥镜检查培训计划中识别出的128位胆道内镜专家。 >结果:回复率为46.1%(59/128)。只有55.6%的人接受过SOM培训,目前有49.2%的人进行过SOM。对于胆汁SOD2,常规获得SOM的占33.3%,进行经验性括约肌切开术的占33.3%,进行单次内镜超声/内镜逆行胰胆管造影(EUS / ERCP)的占26.3%。相比之下,对于疑似急性特发性复发性胰腺炎,相同数量(35.1%)的患者赞成SOM或单次EUS / ERCP治疗,而有19.3%的患者会进行经验性括约肌切开术。与未进行SOM的患者相比,进行SOM的患者在预测对治疗的反应方面很重要(71.8%对23.1%,P = 0.01)。但是,这一组中只有51.7%的人对可疑SOD2执行SOM。大多数(78.6%)的患者认为括约肌切开术后症状的改善少于<50%。未获得SOM的常见原因包括结果不可靠(50%)和与程序相关的风险(39.3%)。大多数(59.3%)的人认为SOD2至少部分是功能性疾病。只有3.7%的人认为SOD是Oddi括约肌的合法疾病。 >结论:我们对美国专家内镜医师的调查表明,SOD2并非常规进行SOM,并且仍然存在与之相关的风险和有效性的担忧。大多数内镜医师认为,SOD2至少部分是在大多数情况下不会对括约肌切开术作出反应的功能性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号